Top Biotechnology companies in Netherlands by Revenue

This ranking features the top 10 Biotechnology companies in Netherlands ranked by Revenue, totalling a Revenue of USD 5.12 B, for January 15, 2025.
#
Name
Revenue
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 1.97 B
Dec. 31, 2023 USD 45.57 -0.94%

Netherlands

2
USD 1.59 B
Dec. 31, 2023 USD 22.92 2.26%

Netherlands

3
USD 1.23 B
Dec. 31, 2023 USD 673.61 1.66%

Netherlands

4
USD 245.32 M
Dec. 31, 2023 USD 9.93 5.98%

Netherlands

5
USD 43.95 M
Dec. 31, 2023 USD 39.01 -3.56%

Netherlands

6
USD 15.84 M
Dec. 31, 2023 USD 13.23 -4.06%

Netherlands

7
USD 12.76 M
Dec. 31, 2023 USD 23.67 -3.70%

Netherlands

8
USD 7.19 M
Dec. 31, 2023 USD 2.26 -0.44%

Netherlands

9
USD 6.77 M
Dec. 31, 2023 USD 0.98 -1.01%

Netherlands

10
USD 0.00
Dec. 31, 2023 USD 16.00 -2.50%

Netherlands

Frequently Asked Questions
  • Which Biotechnology company in Netherlands has the highest Revenue ?

    The Biotechnology company in Netherlands with the highest Revenue is Qiagen N.V. (NYSE: QGEN) at USD 1.97 B.

  • Which Biotechnology company in Netherlands has the lowest Revenue ?

    The Biotechnology company in Netherlands with the lowest Revenue is Pharvaris N.V. (NasdaqGS: PHVS) at USD 0.00.